Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T von Briel

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Acta Neurochirurgica|July 31, 2007
Intradural pleural malignant mesotheliomaM Payer, T von Briel
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)T Cerny, S Leyvraz, T von Briel, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2023
Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort studyA Schuler, J Huser, S Schmid, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Acta Neurochirurgica|July 31, 2007
Intradural pleural malignant mesotheliomaM Payer, T von Briel
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)T Cerny, S Leyvraz, T von Briel, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2023
Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort studyA Schuler, J Huser, S Schmid, et al.
Pageof 1